NCT07320495 Efficacy and Safety of the APGO Algorithm for Automated Insulin Delivery
| NCT ID | NCT07320495 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Charles University, Czech Republic |
| Condition | Diabetes Mellitus Type 1 |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2025-06-19 |
| Primary Completion | 2027-06-19 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2025-06-19 with a primary completion date of 2027-06-19.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Medtrum TouchCare Nano system with the APGO algorithm is the only patch pump-based automated insulin delivery system available in the Czech Republic. However, until now, no prospective clinical study has evaluated its efficacy and safety under real-world conditions. The RENEW study is the first to address this topic.
Eligibility Criteria
Inclusion Criteria: * patients with T1D * type 1 diabetes for ≥1 years * ≥ 18 years old * written informed consent prior to starting study related activity Exclusion Criteria: * severe noncompliance * lactation, pregnancy, intending to become pregnant during study * use of medication with effects on carbohydrate metabolism
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07320495 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Diabetes Mellitus Type 1. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07320495 currently recruiting?
Yes, NCT07320495 is actively recruiting participants. Contact the research team at jan.soupal@seznam.cz for enrollment information.
Where is the NCT07320495 trial being conducted?
This trial is being conducted at Prague, Czechia.
Who is sponsoring the NCT07320495 clinical trial?
NCT07320495 is sponsored by Charles University, Czech Republic. The trial plans to enroll 200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.